Amprius Technologies, Inc. (NYSE:AMPX – Get Free Report) was the recipient of some unusual options trading activity on Thursday. Investors acquired 22,391 call options on the stock. This is an increase of approximately 141% compared to the typical daily volume of 9,288 call options.
Amprius Technologies Stock Up 11.8%
Shares of NYSE:AMPX traded up $1.42 during midday trading on Thursday, reaching $13.40. The company’s stock had a trading volume of 15,015,869 shares, compared to its average volume of 8,045,659. The firm has a market cap of $1.75 billion, a price-to-earnings ratio of -52.11 and a beta of 3.04. The business has a 50 day moving average price of $10.16 and a 200 day moving average price of $9.95. Amprius Technologies has a 1 year low of $1.70 and a 1 year high of $16.03.
Amprius Technologies (NYSE:AMPX – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.03. The firm had revenue of $21.43 million during the quarter, compared to analyst estimates of $16.45 million. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. Sell-side analysts anticipate that Amprius Technologies will post -0.45 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
View Our Latest Research Report on AMPX
Insider Activity
In other news, Director Kang Sun sold 43,185 shares of Amprius Technologies stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $11.03, for a total value of $476,330.55. Following the completion of the sale, the director directly owned 1,403,651 shares of the company’s stock, valued at approximately $15,482,270.53. The trade was a 2.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction that occurred on Thursday, January 22nd. The shares were sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the completion of the transaction, the chief technology officer owned 748,696 shares of the company’s stock, valued at $9,014,299.84. This trade represents a 39.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 3,359,641 shares of company stock valued at $36,572,335. 12.80% of the stock is owned by company insiders.
Institutional Investors Weigh In On Amprius Technologies
A number of hedge funds have recently bought and sold shares of AMPX. Quarry LP bought a new stake in Amprius Technologies during the third quarter valued at $42,000. Jones Financial Companies Lllp boosted its holdings in shares of Amprius Technologies by 353.2% in the 3rd quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company’s stock valued at $50,000 after buying an additional 3,532 shares during the period. Parallel Advisors LLC bought a new stake in shares of Amprius Technologies during the 3rd quarter valued at about $54,000. Geneos Wealth Management Inc. bought a new stake in shares of Amprius Technologies during the 3rd quarter valued at about $74,000. Finally, Ameritas Investment Partners Inc. raised its stake in Amprius Technologies by 2,043.2% during the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock worth $40,000 after acquiring an additional 9,072 shares during the period. Institutional investors and hedge funds own 5.04% of the company’s stock.
Amprius Technologies Company Profile
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
See Also
- Five stocks we like better than Amprius Technologies
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
